🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Head and neck cancer is the malignant tumor with the highest morbidity and ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2023-09-01
Trial ID
NCT06208826
Treatments Being Tested
This study is being done to learn more about a new medicine called PF-08634...
Status
Recruiting
Location
Clearview Cancer Institute (Crestwood)
Start Date
2026-06-30
Trial ID
NCT07489066
Treatments Being Tested
The purpose of study is to compare bladder intact-event free survival (BI-E...
Status
Active Not Recruiting
Location
Loma Linda Univ Faculty Medic
Start Date
2020-12-07
Trial ID
NCT04658862
This Phase 3 study will be conducted in different countries around the worl...
Status
Recruiting
Location
Mt. Sinai Comprehensive Cancer Center
Start Date
2026-04-03
Trial ID
NCT07225270
Treatments Being Tested
This is a single-arm, phase II study that is designed to investigate nodal ...
Status
Recruiting
Location
University of Cincinnati Medical Center
Start Date
2026-05-13
Trial ID
NCT07497607
Treatments Being Tested
This study is a randomized, active-controlled, open-label clinical trial fo...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06647563
This is a randomized, open-label, multi-center, global, Phase III study to ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-06-01
Trial ID
NCT03164616
The main objective is to compare the efficacy of tarlatamab with standard o...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2023-05-31
Trial ID
NCT05740566
Treatments Being Tested
This is a study to evaluate the safety and efficacy of EIK1001 administered...
Status
Recruiting
Location
Southern Cancer Center, P.C.
Start Date
2026-06-15
Trial ID
NCT07365319